Impairment in postischemic neovascularization in mice lacking the CXC chemokine receptor 3

Circulation Research

Volumn 96, Issue 5, 2005, Pages 576-582

  Waeckel, Ludovic ^a   Mallat, Ziad ^a   Potteaux, Stéphane ^a   Combadière, Christophe ^b   Clergue, Michel ^a   Duriez, Micheline ^a   Bao, Lu ^c   Gerard, Craig ^c   Rollins, Barrett J ^d   Tedgui, Alain ^a   Levy, Bernard I ^a   Silvestre, Jean Sébastien ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Angiogenesis; Chemokine receptor; Inflammation; Ischemia

Indexed keywords

ANGIOGENIC FACTOR; ANTIGEN; CD3 ANTIGEN; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MAC 3 ANTIGEN; MONOCYTE CHEMOTACTIC PROTEIN 1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY LIGATION; ARTICLE; BIOACCUMULATION; BLOOD FLOWMETRY; CAPILLARY DENSITY; CELL COUNT; CELL INFILTRATION; CELL ISOLATION; CONTROLLED STUDY; FEMORAL ARTERY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFLAMMATORY CELL; LEG ANGIOGRAPHY; LEG ISCHEMIA; LEUKOCYTE MIGRATION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MONOCYTE; MONONUCLEAR CELL; MOUSE; MOUSE STRAIN; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCORING SYSTEM; T LYMPHOCYTE; TISSUE LEVEL; WILD TYPE;

ANIMALS; ARTERIOLES; BONE MARROW TRANSPLANTATION; CAPILLARIES; CHEMOKINE CCL2; CHEMOKINES, CXC; CHEMOTAXIS, LEUKOCYTE; FEMORAL ARTERY; HINDLIMB; ISCHEMIA; LASER-DOPPLER FLOWMETRY; LIGATION; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, CHEMOKINE; T-LYMPHOCYTE SUBSETS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 20144389706     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000159389.55544.20     Document Type: Article

References (16)

1. Carmeliet P. Angiogenesis in health and disease. Nat Med. 2003;6:653-660.
2. Arras M, Ito WD, Scholz D, Winkler B, Schaper J, Schaper W. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest. 1997;101:40-50.
3. Heil M, Ziegelhoeffer T, Pipp F, Kostin S, Martin S, Clauss M, Schaper W. Blood monocyte concentration is critical for enhancement of collateral artery growth. Am J Physiol Heart Circ Physiol. 2002;283: H2411-H2419.
4. Stabile E, Burnett MS, Watkins C, Kinnaird T, Bachis A, la Sala A, Miller JM, Shou M, Epstein SE, Fuchs S. Impaired arteriogenic response to acute hindlimb ischemia in CD4-knockout mice. Circulation. 2003;108:205-210.
5. -/- mice. Circulation. 1999;99:3188-3198.
6. Sunderkotter C, Goebeler M, Schulze-Osthoff K, Bhardwaj R, Sorg C. Macrophage-derived angiogenesis factor. Pharm Ther. 1991;51:195-216.
7. Silvestre JS, Mallat Z, Duriez M, Tamarat R, Bureau MF, Scherman D, Duverger N, Branellec D, Tedgui A, Levy BI. Antiangiogenic effect of interleukin-10 in ischemia-induced angiogenesis in mice hindlimb. Circ Res. 2000;87:448-452.
8. Silvestre JS, Mallat Z, Tamarat R, Duriez M, Tedgui A, Levy BI. Regulation of Matrix Metalloproteinase activity in ischemic tissue by interleukin-10: role in ischemia-induced angiogenesis. Circ Res. 2001;89:259-264.
9. Mallat Z, Silvestre JS, Le Ricousse-Roussanne S, Lecomte-Raclet L, Corbaz A, Clergue M, Duriez M, Barateau V, Akira S, Tedgui A, Tobelem G, Chvatchko Y, Levy BI. Interleukin-18/interleukin-18 binding protein signaling modulates ischemia-induced neovascularization in mice hindlimb. Circ Res. 2002;91:441-448.
10. Heil M, Ziegelhoeffer T, Wagner S, Fernandez B, Helisch A, Martin S, Tribulova S, Kuziel WA, Bachmann G, Schaper W. Collateral artery growth (arteriogenesis) after experimental arterial occlusion is impaired in mice lacking CC-chemokine receptor-2. Circ Res. 2004;94:671-677.
11. Ito WD, Arras M, Winkler B, Scholz D, Schaper J, Schaper W. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res. 1997;80:829-837.
12. Sauty A, Dziejman M, Taha RA, Iarossi AS, Neote K, Garcia-Zepeda EA, Hamid Q, Luster AD. The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells. J Immunol. 1999;162:3549-3558.
13. Boztug K, Carson MJ, Pham-Mitchell N, Asensio VC, DeMartino J, Campbell IL. Leukocyte infiltration, but not neurodegeneration. in the CNS of transgenic mice with astrocyte production of the CXC chemokine ligand 10. J Immunol. 2002;169:1505-1515.
14. Romagnani P, Annunziato F, Lasagni L, Lazzeri E, Beltrame C, Francalanci M, Uguccioni M, Galli G, Cosmi L, Maurenzig L, Baggiolini M, Maggi E, Romagnani S, Serio M. Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. J Clin Invest. 2001;107:53-63.
15. Bonacchi A, Romagnani P, Romanelli RG, Efsen E, Annunziato F, Lasagni L, Francalanci M, Serio M, Laffi G, Pinzani M, Gentilini P, Marra F. Signal transduction by the chemokine receptor CXCR3: activation of Ras/ERK, Src. and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes. J Biol Chem. 2001;276:9945-9954.
16. Lasagni L, Francalanci M, Annunziato F, Lazzeri E, Giannini S, Cosmi L, Sagrinati C, Mazzinghi B, Orlando C, Maggi E, Marra F, Romagnani S, Serio M, Romagnani P. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. J Exp Med. 2003;197:1537-1549.